Targeting nuclear import and export in hematological malignancies.
Targeting nuclear import and export in hematological malignancies.
复制标题
DOI:
10.1038/s41375-020-0958-y
复制
发表时间:
2020-11
期刊:
影响因子:
11.4
通讯作者:
Schimmer AD
中科院分区:
文献类型:
--
作者:
Nachmias B;Schimmer AD
The transport of proteins across the nuclear membrane is a highly regulated process, essential for the cell function. This transport is actively mediated by members of the karyopherin family, termed importins, or exportins, depending on the direction of transport. These proteins play an active part in tumorigenesis, through aberrant localization of their cargoes, which include oncogenes, tumor-suppressor genes and mediators of key signal transduction pathways. Overexpression of importins and exportins is reported in many malignancies, with implications in cell growth and viability, differentiation, drug resistance, and tumor microenvironment. Given their broad significance across tumors and pathways, much effort is being put to develop specific inhibitors as a novel anticancer therapeutics. Already, selinexor, a specific inhibitor of exportin-1 (XPO1), is approved for clinical use. This review will focus on the role of importins and exportins in hematological malignancies. We will discuss current preclinical and clinical data on importins and exportins, and demonstrate how our growing understanding of their functions has identified new therapeutic targets.
登录
查看更多内容
影响因子:
20.3
作者:
Chen, Christine;Siegel, David;Reece, Donna
通讯作者:
Reece, Donna
影响因子:
28.5
作者:
Camus V;Miloudi H;Taly A;Sola B;Jardin F
通讯作者:
Jardin F
影响因子:
3.7
作者:
Chopra, Martin;Bohlander, Stefan K.
通讯作者:
Bohlander, Stefan K.
影响因子:
20.3
作者:
Falini, Brunangelo;Bolli, Niccolò;Nicoletti, Ildo
通讯作者:
Nicoletti, Ildo
影响因子:
3.7
作者:
Edick, MJ;Cheng, C;Relling, MV
通讯作者:
Relling, MV